IDiyas

For the Inventor, By the Inventor

Frederiksberg, Denmark

Ingrid Pettersson

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 265(Granted Patents)


Company Filing History:

goldMedal19 out of 1,777 
 
Novo Nordisk A/s
 patents
silverMedal6 out of 50 
 
High Point Pharmaceuticals, LLC
 patents
bronzeMedal4 out of 52 
 
Vtv Therapeutics LLC
 patents
4. 1 out of 1 
 
Novo Novdisk A/s
 patent

Years Active: 2001-2022

Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents
1. 11420929 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2022-08-23),
2. 11208452 - Insulins with polar recombinant extensions (2021-12-28),
3. 10919949 - Acylated insulin analogues and uses thereof (2021-02-16),
4. 10471066 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2019-11-12),
5. 10195255 - GLP-1 derivatives and uses thereof (2019-02-05),
6. 9855274 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2018-01-02),
7. 9663481 - Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists (2017-05-30),
8. 9657079 - Truncated GLP-1 derivatives and their therapeutical use (2017-05-23),
9. 9409966 - Glucagon-like peptide-1 derivatives and their pharmaceutical use (2016-08-09),
10. 8895694 - Glucagon-Like Peptide-1 derivatives and their pharmaceutical use (2014-11-25),
11. 8551993 - Phenoxy acetic acids as PPAR delta activators (2013-10-08),
12. 8362016 - Phenyl propionic acids as PPAR delta activators (2013-01-29),
13. 7968723 - Compounds, their preparation and use (2011-06-28),
14. 7943613 - Compounds, their preparation and use (2011-05-17),
15. 7799924 - Substituted homopiperidine, piperidine or pyrrolidine derivatives (2010-09-21),

Title: **Ingrid Pettersson: Innovator in the Field of Biotechnology**

Introduction

Ingrid Pettersson, an accomplished inventor based in Frederiksberg, Denmark, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 30 patents, her work primarily focuses on improving drug formulations and treatment methods for various medical conditions, particularly in diabetes care.

Latest Patents

Two of Ingrid's latest patents highlight her innovative approach to drug development. The first, titled "Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists," presents compounds that activate PPARδ, potentially beneficial for enhancing mitochondrial energy output and treating related conditions. The second patent, "Insulins with polar recombinant extensions," introduces novel insulin analogues featuring polar amino acid sequences designed to improve the drug's half-life and stability. This invention offers new pharmaceutical compositions for the treatment and prevention of diabetes-related medical conditions.

Career Highlights

Ingrid has held key positions at prominent companies in the pharmaceutical sector, including Novo Nordisk A/S and High Point Pharmaceuticals, LLC. These roles have allowed her to leverage her expertise in drug formulation and development, contributing to her success as an inventor.

Collaborations

Throughout her career, Ingrid has collaborated with notable professionals, including Per Sauerberg and John Patrick Mogensen. These partnerships have enriched her inventive process and provided opportunities for innovative research to flourish.

Conclusion

With a robust array of patents and a commitment to advancing biotechnology, Ingrid Pettersson stands out as a leading figure in her field. Her groundbreaking work not only enhances our understanding of drug efficacy and stability but also promises significant improvements in medical treatments for conditions such as diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…